Çѱ¹º¸°ÇÀÇ·á±â¼úÆò°¡ÇÐȸ(ÀÌÇÏ “Æò°¡ÇÐȸ”)¿Í Çѱ¹º¸°ÇÀǷῬ±¸¿ø(ÀÌÇÏ “¿¬±¸¿ø”)Àº »óÈ£ ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î ¡¸º¸°ÇÀÇ·á±â¼úÆò°¡¡¹ ÇмúÁö(ÀÌÇÏ “°øµ¿ ÇмúÁö”)¸¦ °øµ¿ ¹ßÇàÇÑ´Ù. º¸°ÇÀÇ·á±â¼úÆò°¡´Â º¸°ÇÀÇ·á±â¼ú¿¡ ¼ÓÇÏ´Â ¾àÁ¦, ÀÇ·áÀåºñ³ª ±â±¸, °¢Á¾ ¼ö¼úÀ̳ª ½Ã¼ú, º¸°ÇÀÇ·á Áö¿øÃ¼°è, º¸°ÇÀÇ·áü°è µî°ú °ü·ÃµÈ ±ÛÀ» °ÔÀçÇÏ´Â ÇмúÁöÀÌ´Ù. ¿ø°íÀÇ Á¾·ù´Â ¿øÀú, Á¾¼³, ƯÁý, Áõ·Ê, ÆíÁýÀÎÀÇ ±Û, ¼Æò, ÆíÁýÀο¡°Ô º¸³»´Â ±Û µîÀ¸·Î ÇÑ´Ù.
- º»¹®
A.¼·Ð
¨ç ³í¹®ÀÇ ¸ñÀûÀ» ¾ð±ÞÇϰí, ¿¬±¸³ª °üÂûÀÇ ±Ù°Å¸¦ ¿ä¾àÇÑ´Ù.
¨è Âü°í¹®ÇåÀº °ü°è ÀÖ´Â °Í¸¸ ¾ö°ÝÈ÷ °ñ¶ó ³ª¿ÇÑ´Ù.
¨é ¼·Ð¿¡´Â ³í¹® Àڷᳪ ³í¹®ÀÇ °á·ÐÀ» Æ÷ÇÔÇÏÁö ¾Ê´Â´Ù
B. ¹æ¹ý
¨ç °üÂû ´ë»óÀ̳ª ½ÇÇè ´ë»óÀÚ(ȯÀÚ, ½ÇÇ赿¹° ¹× ´ëÁ¶±º) ¼±Á¤ ¹æ¹ý À» ¸íÈ®È÷ ±â¼úÇÑ´Ù. ´ë»óÀÚÀÇ ¿¬·É, ¼ºº° ¹× ±âŸ Áß¿äÇÑ Æ¯Â¡À» ±âÀçÇÑ´Ù.
¨è ½ÇÇè(¶Ç´Â °üÂû) ¹æ¹ý, ÀåÄ¡³ª ±â±¸(Á¦Á¶È¸»ç À̸§°ú ÁÖ¼Ò¸¦ °ýÈ£ ¼Ó¿¡ Á¦½Ã) ¹× ½ÇÇè °úÁ¤Àº ´Ù¸¥ ¿¬±¸ÀÚ°¡ °á°ú¸¦ ÀçÇöÇÒ ¼ö ÀÖÀ» Á¤µµ·Î ÀÚ¼¼È÷ ±â·ÏÇÑ´Ù. Àß ¾Ë·ÁÁø ¹æ¹ý¿¡ ´ëÇØ¼´Â Âü°í¹®Ç常 À»
±â·ÏÇÒ ¼ö ÀÖ´Ù. ÃâÆÇµÈ ¹æ¹ýÀÌÁö¸¸ Àß ¾Ë·ÁÁöÁö´Â ¾ÊÀº ¹æ¹ýÀÎ °æ¿ì Âü°í¹®ÇåÀ» ´Þ°í ª°Ô ±â¼úÇÑ´Ù. »õ·Î¿î ¹æ¹ýÀ» »ç¿ëÇ߰ųª »õ·Ó´Ù°í ÇÒ Á¤µµ·Î º¯Çü½ÃÄÑ »ç¿ëÇÑ °æ¿ì¿¡´Â ±× ¹æ¹ýÀ» »ç¿ëÇÑ ÀÌÀ¯¿Í ±× ¹æ¹ýÀÇ
ÇѰ踦 Æò°¡ÇØ¾ß ÇÑ´Ù.
¨é »ç¿ëÇÑ ¾àǰ°ú ÈÇй°ÁúÀº °¢°¢ÀÇ ÀϹݸí, ¿ë·®, ÅõÀÔ¹æ¹ýÀ» Æ÷ÇÔ ÇÏ¿© ¸ðµÎ Á¦½ÃÇÑ´Ù.
C. °á°ú
¿¬±¸°á°ú´Â °¡´ÉÇÑ Ç¥¿Í ±×¸²À» »ç¿ëÇÏ¿© °£·«È÷ Ç¥½ÃÇϸç, ºÒ°¡ÇÇÇÑ °æ¿ì°¡ ¾Æ´Ï¸é Áߺ¹ ¼¼úÇÏÁö ¾Ê´Â´Ù.
D. °íÂû
¨ç ¼·ÐÀ̳ª °á°ú Ç׸ñ¿¡ ±â¼úÇÑ ¿¬±¸ ÀڷḦ ¹Ýº¹ÇÏ¿© ¼¼úÇÏÁö ¾Ê´Â´Ù.
¨è °íÂû Ç׸ñ¿¡´Â ¿¬±¸ ¼Ò°ßÀÇ ÀǹÌ, ±× ÀǹÌÀÇ ÇѰè, ±×¸®°í Àå·¡ ¿¬±¸¿¡ ¹ÌÄ¡´Â ¿µÇâ µîÀ» Æ÷ÇÔ½ÃŲ´Ù. °üÂû °á°ú¸¦ ´Ù¸¥ À¯»çÇÑ ¿¬±¸ ¿Í ºñ±³ÇÑ´Ù.
E. °á·Ð
¨ç ¿¬±¸ÀÇ °á°ú·ÎºÎÅÍ ¾òÀº °á·Ð µîÀ» °Á¶ÇÑ´Ù. - º»¹®¿¡¼ÀÇ Âü°í¹®ÇåÀÇ Àοë: º»¹®°ú µµÇ¥ Áß¿¡¼ Âü°í¹®ÇåÀ» Àοë ÇÒ ¶§¿¡´Â ÀÎ¿ë ¼ø¼¿¡ µû¶ó ¿À¸¥ÂÊ ¹Ý°ýÈ£¾È¿¡ ¾Æ¶óºñ¾Æ
¼ýÀÚ·Î ¾î±ú¹øÈ£¸¦ ºÙÀδÙ. ¾î±ú¹øÈ£´Â ½°Ç¥·Î¼ ±¸ºÐÇϸç 3°³ ÀÌ»óÀÇ ¿¬¼Ó µÈ ¼ýÀÚ´Â ‘-’¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ´Ù(ÀúÀÚ¸íÀÇ Ç¥±â´Â µÎ ¸í±îÁö´Â ¸ðµÎ Ç¥±âÇÏ°í ¼¼ ¸í ÀÌ»óÀº Á¦1ÀúÀÚ¸¸
Ç¥±âÇÑ´Ù). ¹®ÀåÀÇ ¸¶Áö¸·¿¡ Âü°í ¹®ÇåÀÌ µé¾î°¥ ¶§´Â ¸¶Ä§Ç¥( . ) ´ÙÀ½¿¡ Âü°í¹®Çå ¾î±ú¹øÈ£¸¦ ±âÀÔÇÑ ´Ù. (¿¹) ÇÑÆí È«±æµ¿1)À̳ª Kay¿Í Tasman2,7-10)Àº Á¤½ÅºÐ¿º´ÀÇ À½¼º Áõ»óÀÌ
´ë³ú ÆíÃø¼ºÀÇ ÀÌ»ó°ú °ü·ÃÀÌ ÀÖ´Ù°í º¸°íÇÏ¿´´Ù.
F. °¨»çÀÇ ±Û(Acknowledgments)
¨ç »ý·«ÇÒ ¼ö ÀÖ´Ù.
G. Âü°í¹®Çå
¨ç Âü°í¹®ÇåÀº º»¹®°ú µµÇ¥¿¡ óÀ½ ÀοëµÇ´Â ¼ø¼¿¡ µû¶ó ¹øÈ£¸¦ ¸Å°Ü ¿°ÅÇÑ´Ù. µ¿ÀÏ ÀúÀÚÀÇ °æ¿ì ¿¬µµ¼øÀ¸·Î ³ª¿ÇÑ´Ù.
¨è Âü°í¹®ÇåÀº º»¹®¿¡ ³ªÅ¸³ °Í¸¸ ÀοëÀÌ °¡´ÉÇϸç, 30°³ À̳»·Î ÇÑ´Ù(´Ü, Á¾¼³ÀÎ °æ¿ì´Â ¿¹¿Ü·Î ÇÑ´Ù).
¨é ÀοëÇÑ Âü°í¹®ÇåÀÌ ±¹³»¿¡¼ ¹ß°£µÈ ¹®ÇåÀÌ¶óµµ ¹®Çå¸í, Á¦¸ñ, ÀúÀÚ µî¿¡ ´ëÇÑ ¿µ¹® Á¤º¸°¡ Á¦°øµÇ¾î ÀÖ´Â °æ¿ì ¿µ¹®À¸·Î Ç¥±âÇÏ´Â °ÍÀ» ¿øÄ¢À¸·Î ÇÑ´Ù.
¨ê Âü°í¹®Çå ÀúÀÚ´Â 6ÀÎ À̳»ÀÇ °æ¿ì ¸ðµÎ ±âÀçÇϰí, 7ÀÎ ÀÌ»óÀº 6ÀαîÁö ±âÀçÇÑ ÈÄ et al. ¶Ç´Â ‘µî’À» ºÙÀ̸ç, ÀúÀÚ¸íÀÇ Ç¥±â´Â ±¹¹®ÀÇ °æ¿ì´Â ´Ù Ç¥±âÇϸç, ¿µ¹®ÀÇ
°æ¿ì last nameÀº ´Ù ¾²°í, first name°ú middle nameÀº ù ±ÛÀÚ¸¦ ´ë¹®ÀÚ·Î ºÙ¿© ¾²°í initial¿¡´Â ¸¶Ä§Ç¥( . )´Â »ç¿ëÇÏÁö ¾Ê´Â´Ù. ÀúÀÚ¸í »çÀÌ¿¡´Â ½°Ç¥( , )·Î
±¸ºÐÇϰí, ¸¶Áö¸· Àú ÀÚ¸í ¶Ç´Â et alÀÇ µÚ¿¡´Â ¸¶Ä§Ç¥( . )¸¦ Âï´Â´Ù. ±¹¹®ÀÇ °æ¿ì¿¡µµ µ¿ ÀÏÇÏ´Ù.
¨ë ÀâÁö¸íÀº ‘List of Journals Indexed in Index Medicus’¿¡ Àǰоà¾î·Î ±âÀçÇÑ´Ù. Àοë³í¹®ÀÇ Á¦¸ñ Áß Ã¹ ±ÛÀÚ´Â ´ë¹®ÀÚ·Î Çϰí, ºÎÁ¦¸ñÀÌ
ÀÖ´Â °æ¿ì ½ÖÁ¡( : )À» ºÙÀÎ ÈÄ ¼Ò¹®ÀÚ·Î ±âÀçÇϸç Á¦¸ñ µÚ¿¡´Â ¸¶Ä§ Ç¥( . )·Î Ç¥½ÃÇÑ´Ù. ¿¬µµ¸¦ Ç¥½ÃÇÑ ÈÄ ½Ö¹ÝÁ¡( ; )À» ºÙ¿©¼ ±¸ºÐ ÈÄ, ÀâÁö¸í, ±Ç£º½ÃÀÛ ÆäÀÌÁö-³¡ ÆäÀÌÁöÀÇ ¼øÀ¸·Î
ÇÑ´Ù. ³¡ ÆäÀÌÁö´Â ½ÃÀÛ ÆäÀÌÁö¿¡¼ º¯ÈµÈ ¼ýÀÚ¸¸ ±âÀÔÇÏÁö ¸»°í ÀüºÎ ±âÀÔÇϵµ·Ï ÇÑ ´Ù. Âü°í¹®Çå Áß Àοë ÇмúÁö¸í µÚ¿¡´Â ¸¶Ä§Ç¥¸¦ ÂïÁö ¾Ê°í Âü°í¹®Çå ³¡¿¡ ¸¶Ä§Ç¥¸¦ Âï´Â´Ù.
¡á Âü°í¹®Çå ¿¹
- Á¤±â ÇмúÁö ³í¹®
1) Lumley T. Network meta-analysis for indirect treatment compari sons. Statistics in Medicine
2002;21:2313-2324.
2) ÇѼ°æ, ±èÀ±Èñ, ÀåÀºÁø, ¾ÈÁ¤ÈÆ, °¼öÈñ, ±è¼±Èñ. °£Á¢ºñ±³¸¦ ÅëÇÑ º¸°ÇÀÇ·á±â¼úÀÇ À¯¿ë¼º Æò°¡¿¡¼ ºÐ¼®°á°úÀÇ Å¸´ç¼º È®º¸¸¦ À§ÇÑ Á¶°Ç. Çѱ¹º¸°ÇÁ¤º¸Åë°èÇÐȸÁö 2011;36:25-35.
→ Hahn S, Kim Y, Jang E, Ahn J, Kang S, Kim SH. Assessing the valid condition for indirect comparisons in
evaluation of healthcare interventions. Journal of the Korean Society of Health Information and Health
Statistics 2011;36:25-35.
- ÃâÆÇ ÁßÀÎ ÀÚ·áÀÇ Àοë
1) Neumann PJ. Lessons for health technology assessment: it is not only about the evidence. Value in Health
2009.
- ´ÜÇົÀÇ Àοë
1) Sutton AJ. Methods for meta-analysis in medical research. 10th ed. New York: John Wily &
Sons;2001. pp.121-125.
2) ·ù½Ã¿ø, Á¶Çö, ±è±¤È¯, ¹Ú±æÇÏ, ¹ÚÂù¼®. º¸°ÇÀÇ·áÁ¤º¸ÇÐ. 2ÆÇ. ¼¿ï: °èÃ๮Ȼç;2012. pp.35-50.
- ÆíÀúÀÇ Àοë
1) Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions. New
York: Wiley-Blackwell;2008. pp.132137.
2) È«±æµ¿ ÆíÀú. º¸°ÇÀÇ·á±â¼úÆò°¡. ¼¿ï: ÀÏÁö»ç;2002. pp.40-48.
- Ã¥ÀÇ ´Ü¿øÀÇ ÀÌ¿ë
1) Luce BR, Manning WG, Siegel JE. Estimating costs in cost-effectiveness analysis. In: Gold MR,
Siegel JE, Russell LB, editors. Costeffectiveness in Health and Medicine. New York: Oxford University
Press;1996. pp.162-178.
2) Honingsbaum P. Priority Setting Processes for Healthcare. Abingdon: Radcliffe Medical
Press;1995. pp.304-306.
3) ¹è¸í¼ö. º¸°ÇÀÇ·á»ç¾÷·Ð. ±è¿î½Å ÆíÀú. º¸°ÇÀÇ·áÇàÁ¤·Ð. ¼¿ï: ¼ö¹® »ç;2006. pp.245-263.
- ÀúÀڹ̻ó
1) ÀúÀÚ ¹Ì»ó. Çѱ¹º¸°ÇÀÇ·á±â¼ú. ¼¿ï: ¹Î´ã»ç;1958. pp.30-70.
2) Anonymous. Pharmaceutical price regulation. London: Saunders;1999. pp.8-46.
- Çмú´ëȸ³ª ¿¬¼ö±³À°¿¡¼ ¹ßÇ¥µÈ °á°ú Àοë
1) À̼±Èñ. ±¹¹Î°Ç°º¸Çè º¸À强 °ÈÁ¤Ã¥ Æò°¡. Çѱ¹º¸°ÇÇàÁ¤ÇÐȸ Á¦ 40ȸ Àü±âÇмú´ëȸ; 2008³â 5¿ù 23ÀÏ. ¼¿ï: Çѱ¹º¸°ÇÇàÁ¤ÇÐȸ Àü±â Çмú´ëȸ ¿¬Á¦Áý;2008.
pp.17-52.
2) Goodin A, Blumenschein K, Freeman PR, Talbert J, editors. Prescription drug monitoring
programs: The patient perspective. Proceedings of the 16th ISPOR annual international meeting; 2011 May 21-25;
Baltimore, USA. New York: Springer;2011.
3) Christensen S, Oppacher F. An analysis of Koza’s computational effort statistic for
genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming.
EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale,
Ireland. Berlin: Springer;2002. pp.182-191.
- ÇÐÀ§³í¹®ÀÇ Àοë
1) Á¶°æ¹Ì. ÀǾàǰ »ç¿ëÆò°¡ÀÇ ÇöȲ°ú °³¼±¹æÇâ °ËÅä [¼®»çÇÐÀ§]. ¼¿ï: ÀÌÈ¿©ÀÚ´ëÇб³;2009.
2) Raftery J. Potential use of routine databases in health technology assessment [dissertation].
Oxford: University of Oxford;1995.
- ½Å¹®±â»çÀÇ Àοë
1) ÀÌÀººó. ÀÇ·á±â¼úÆò°¡¿¡ ²À ÇÊ¿äÇÑ °ÍÀº?. ÀÇÇù½Å¹® 2013³â 3¿ù 15 ÀÏ;2¸é.
2) Scharr J. 3 health technology solutions from student entrepreneurs. The Washington Post. 2002
Aug 12;Sect. A:2 (col. 4).
- ½Ãû°¢ ÀڷḦ ÀοëÇÒ ¶§
1) Pharmaceutical pricing and reimbursement information(PPRI) [videocassette]. St. Louis(MO):
Mosby-Year Book;1995.
- ÀüÀÚ ÀÚ·áÀÇ Àοë
<ÀÎÅͳݻóÀÇ ³í¹®À» ÀοëÇÒ ¶§>
1) Abrams K, Jones DR. Meta-analysis and the synthesis of evidence. Mathematical Medicine and
Biology [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1)[24 screens]. Available from: http://imammb.
oxfordjournals.org/content/12/3-4/297.short.
<ÀÎÅÍ³Ý È¨ÆäÀÌÁö/À¥»çÀÌÆ®¸¦ ÀοëÇÒ ¶§>
1) who.int [Homepage on the Internet]. Geneva: WHO; c2010-01 [updated 2011 Sep 16; cited 2011 Dec
20]. Available from: http:// www.who.int/en/.
<CD-ROMÀ» ÀοëÇÒ ¶§>
1) Kruger K. The business of healthcare innovation [CD-ROM]. Philadelphia: Lippincott Williams
& Wilkins;2005.
- ±âŸ Âü°í¹®Çå ±ÔÁ¤Àº International Committee of Medical Journal Editors Uniform Requirements for
Manuscripts Submitted to Biomedical JournalsÀ» µû ¸¥ ´Ù(http://www.nlm.nih.gov/bsd/uniform_ requirements.html).
1) Åõ°íµÈ ³í¹®Àº ³í¹® 1Æí´ç 2ÀÎÀÇ ½É»çÀ§¿øÀ» À§ÃËÇÑ´Ù. ½É»çÀ§¿øÀº Àü¹®ºÐ¾ßº° ÆíÁýÀ§¿øÀÇ ÃßõÀ» ¹Þ¾Æ ÆíÁýÀ§¿øÀåÀÌ À§ÃËÇϸç, ±¸Ã¼ÀûÀÎ »çÇ×Àº ÆíÁýÀ§¿øÈ¸ ¿î¿µ¿¡ °üÇÑ ±ÔÁ¤¿¡ µû¸¥´Ù. À§Ã˽ɻçÀ§¿øµéÀÇ ½Å»óÀº ÀÏü ºñ¹Ð·Î ÇÏ¸ç ¸ðµç ½É»ç°úÁ¤¿¡¼ ÀúÀڵ鿡°Ô °ø°³µÇ¾î¼´Â ¾Æ´Ï µÈ´Ù.
2) Á¦ÃâµÈ ³í¹®À» ½É»çÇÒ ½É»çÀ§¿øÀº ´ÙÀ½ÀÇ ±âÁØÀ¸·Î ½É»çÇÑ´Ù. ¨ç ¿¬±¸ Àü¹® ºÐ¾ß ¨è ¿¬±¸ ³í¹® ¸ñ·Ï ¨é ¿¬±¸ °æ·Â ¨ê ±âŸ °í·Á »çÇ×
3) ÆíÁýÀ§¿øÈ¸¿¡¼ ½É»çÀ§¿ø¿¡°Ô ³í¹®ÀÇ ½É»ç¸¦ ÀÇ·ÚÇÒ ¶§¿¡´Â ³í¹® Åõ°íÀÚÀÇ ÀÎÀû»çÇ׿¡ ´ëÇØ¼´Â ÀÏü ¹àÈ÷Áö ¾Ê´Â´Ù. ½É»çÀ§¿øÀº ºñ°ø°³·Î À§ÃËÇÔÀ» ¿øÄ¢À¸·Î Çϸç, Åõ°íÀÚ¿¡°Ô´Â ½É»çÀǰ߼¸¸À» Å뺸ÇÑ´Ù.
4) ³í¹®½É»çÀ§¿øÀº À§ÃË ÈÄ 2ÁÖ À̳»¿¡ ½É»ç°á°ú¸¦ ÁÖ¾îÁø ¾ç½Ä¿¡ µû¶ó ÆíÁýÀ§¿øÈ¸¿¡ ¹ß¼ÛÇÏ¿©¾ß ÇÑ´Ù. ±×·¸Áö ¾ÊÀ» °æ¿ì ÆíÁýÀ§¿øÀå ¸íÀÇ ÀÇ µ¶Ã˰ø¹®ÀÌ Áï½Ã ¹ß¼ÛµÇ¸ç, ±×·ÎºÎÅÍ 1ÁÖ À̳»¿¡ ½É»ç°¡ ÀÌ·ç¾îÁöÁö ¾ÊÀ¸¸é ´Ù¸¥ ½É»çÀ§¿øÀ» À§ÃËÇÏ¿© ½É»ç¸¦ ÁøÇàÇÒ ¼ö ÀÖ´Ù.
5) Åõ°íÀÚ´Â ½É»ç¿Ï·á ÈÄ 4ÁÖ À̳»¿¡ ¼öÁ¤ÇÑ ³í¹®À» Á¦ÃâÇÏ¿©¾ß ÇÑ´Ù. ¼öÁ¤µÇ¾î Àç Á¦ÃâµÈ ¿ø°í´Â ÇÊ¿äÇϸé ÃâÆÇ °¡´ÉÇÑ ¼öÁØÀÌ µÉ ¶§±îÁö ÆíÁýÀÎÀÌ Àç½É»ç¿Í Àç¼öÁ¤À» ÇÒ ¼ö ÀÖÀ¸¸ç, ¼öÁ¤º»ÀÌ¶óµµ °ÔÀ縦 °ÅºÎ ÇÒ ¼ö ÀÖ´Ù.
6) ½É»çÆÇÁ¤Àº ‘°ÔÀç°¡’, ‘¼öÁ¤ ÈÄ °ÔÀç’, ‘¼öÁ¤ ÈÄ Àç½É’, ‘°ÔÀçºÒ°¡’ÀÇ 4Á¾À¸·Î ±¸ºÐµÈ´Ù. ‘°ÔÀç°¡’ ÆÇÁ¤µÈ ³í¹®Àº ¼öÁ¤ ¾øÀÌ Ã¤ÅÃÇϸç, ‘¼öÁ¤ ÈÄ °ÔÀç’ ÆÇÁ¤µÈ ³í¹®Àº ÀúÀÚ¼öÁ¤ ÈÄ ÆíÁýÀ§¿øÈ¸ È®ÀÎ ÈÄ °ÔÀçÇϸç, ‘¼öÁ¤ ÈÄ Àç½É’ ÆÇÁ¤µÈ ³í¹®Àº ÀúÀÚ ¼öÁ¤ ÈÄ ½É»çÀ§¿øÀÇ Àç½É»ç¸¦ ÅëÇØ ÀûÇÕ ¿©ºÎ°¡ °áÁ¤µÈ´Ù. ½É»ç ÀÌÀüÀÌ¶óµµ ÇмúÁö °ÔÀç¿¡ ÀûÇÕÇÏÁö ¾Ê´Ù°í ÆÇ´ÜµÇ¸é ÆíÁýÀ§¿øÀåÀÌ ‘°ÔÀçºÒ°¡’·Î ÆÇÁ¤ÇÒ ¼ö ÀÖ´Ù. ³í¹®½É»ç°á°ú´Â ÀúÀÚ À̿ܿ¡´Â ¿ÜºÎ¿¡ °ø°³ÇÏÁö ¾Ê´Â´Ù.
7) ½É»çÀ§¿ø°ú Åõ°íÀÚ´Â ÆíÁýÀ§¿øÈ¸ÀÇ Áß°³·Î À͸íÀ¸·Î °á°úÆÇÁ¤¿¡ °üÇÑ ÀǰßÀ» ±³È¯ÇÒ ¼ö ÀÖÀ¸¸ç, ÃÖÁ¾ÆÇÁ¤Àº ÆíÁýÀ§¿øÈ¸ÀÇ °áÁ¤¿¡ µû¸¥´Ù. ÀÌ ÆÇÁ¤°á°ú¿¡ ´ëÇÏ¿© ½É»çÀ§¿ø°ú Åõ°íÀÚ´Â ÀÌÀǸ¦ Á¦±âÇÒ ¼ö ¾ø´Ù.
º» ±ÔÁ¤¿¡ ¸í½ÃµÇÁö ¾ÊÀº ¸ðµç »çÇ×Àº ÆíÁýÀ§¿øÈ¸ÀÇ °áÁ¤¿¡ µû¸¥´Ù.